Letter to the Editor

Test and Treat H. Pylori Eradication in Dyspepsia—“A Bridge too Far” in the Concensus?

Subjects

  • Subscribe to The American Journal of Gastroenterology for full access:

    $870

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , , et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.

  2. 2.

    , , et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014;63:262–271.

  3. 3.

    , , et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015;64:1353–1367.

  4. 4.

    , , et al. Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis. World J Gastroenterol 2016;22:3486–3495.

  5. 5.

    , , et al. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia. Aliment Pharmacol Ther 2017;45:767–776.

Download references

Author information

Affiliations

  1. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

    • Wojciech Marlicz
  2. Department of Biochemistry and Human Nutrition, Pomeranian Medical University, Szczecin, Poland

    • Karolina Skonieczna-Zydecka
    •  & Igor Łoniewski

Authors

  1. Search for Wojciech Marlicz in:

  2. Search for Karolina Skonieczna-Zydecka in:

  3. Search for Igor Łoniewski in:

Competing interests

Guarantor of the article: Wojciech Marlicz MD, PhD, FACG.

Specific author contributions: W.M., K.S.Z., I.L. conceived the idea, analyzed the data, and drafted the manuscript. All authors have approved the final draft submitted.

Financial support: None.

Potential competing interests: None.

Corresponding author

Correspondence to Wojciech Marlicz.